ninety patients were entered into a randomized , controlled , double-blind trial lasting 12 months to compare auranofin ( 6 mg/d ) , and d-penicillamine ( 250 mg/d for 4 weeks , 500 mg/d for 4 weeks , then 750 mg/d thereafter ) in the treatment of rheumatoid arthritis .
C0030817
penicillamine
C0003873
rheumatoid arthritis